INTRODUCTION
Traditional medicinal plants have been used to treat bacterial infections in many parts of the world for centuries. [1, 2] The use of commercially available antibiotics has revolutionised the treatment of microbial infection. Unfortunately, their indiscriminate usage has resulted in multiple drug resistances towards many antibiotics [3] and an increase in the search for antimicrobial agents from natural sources. [4] Some studies focusing on the investigation of traditional African, [5, 6] Caribbean, [7] and Indian [8] medicinal plants have identified new sources of therapeutic agents. Plant-derived antimicrobial agents are a largely untapped resource with enormous medical potential and much more investigation is needed in this area.
The genus Callistemon (family Myrtaceae) consists of 34 species endemic to Australia. Some species have also been introduced to other areas such as USA [9] and Africa [10] where they are often considered to be invasive species. They are closely related to Melaleucas which have similar leaf and flower morphology. [11, 12] Callistemons are commonly referred to as 'bottlebrushes' due to the appearance of their flowers. They occur naturally in temperate regions of Australia, particularly on the east and south-west coasts.
Callistemon flowers were used as a food source by Australian Aborigines. The flowers were sucked for their nectar or used of approximately 10 8 cells ml -1 for bacteria, or 10 5 cells ml -1 for fungi. 100 µl of microbial suspension was spread onto agar plates corresponding to the broth in which they were maintained.
The extracts were tested using 6 mm sterilised filter paper discs. Discs were impregnated with 10 µl of the test sample, allowed to dry and placed onto inoculated plates. For fungi, nystatin discs (100 µg, Oxoid Ltd.) were used as a positive control. Filter discs impregnated with 10 µl of distilled water were used as a negative control.
Bacterial Growth Time Course Assay
Bacterial growth time course studies were performed as previously described. [19, 20] Briefly, 3 ml of bacterial cultures (Bacillus cereus, Bacillus subtilis, Aeromonas hydrophilia, Pseudomonas fluorescens) in nutrient broth were added to 27 ml nutrient broth containing 3 ml C. citrinus or C. salignus flower extracts (diluted 1 in 100 in sterile deionised water). The tubes were incubated at 30 °C with gentle shaking. The optical density was measured at 550 nm after 0, 1, 2, 4 and 6 h incubations. Control tubes were incubated under the same conditions but without the extract. All assays were performed in triplicate.
Toxicity Screening Reference Toxins for Toxicity Screening
Potassium dichromate (K 2 Cr 2 O 7 ) (AR grade, Chem-Supply, Australia) was prepared as a 1.6 mg/ml solution in distilled water and was serially diluted in artificial seawater for use in the Artemia franciscana nauplii bioassay. Mevinphos (2-methoxycarbonyl-1-methylvinyl dimethyl phosphate) was obtained from Sigma-Aldrich as a mixture of cis (76.6%) and trans (23.0%) isomers and prepared as a 4 mg/ml stock in distilled water. The stock was serially diluted in artificial seawater for use in the bioassay.
to make sweet drinks. [13] Callistemon species also had roles as traditional bush medicines for Australian Aborigines [1, 14] The leaves were used to cure respiratory tract infections. Unfortunately most of our understanding of the antimicrobial potential of Australian Callistemon species is anecdotal with few species being properly studied. It has been postulated that terpenes in the leaves may be responsible for the efficacy of Callistemons in traditional treatments. [14] A recent report has demonstrated the antibacterial activity of a related Callistemon species (Callistemon rigidus). [15] Studies within this laboratory have also found antibacterial activity in methanolic extracts of Callistemon citrinus and Callistemon salignus leaves and flowers against a limited panel of bacteria.
[16] The current study was undertaken to validate and extend these observations against a wider panel of bacteria and fungi, and to assess the toxicity of the extracts and thus to assess their medicinal potential.
MATERIALS AND METHODS

Plant Collection and Extraction
The extracts investigated in this study have been described previously. [16] Briefly, Callistemon citrinus (leaves and flowers) and Callistemon salignus (leaves and flowers) were collected from verified trees in Brisbane, Australia. Samples were dried in a Sunbeam food dehydrator and the dried material was ground to a coarse powder. 1 g of each of the powdered samples was extracted extensively in 50 ml methanol (Ajax, AR grade) for 24 hours at 4 °C with gentle shaking. The extract was filtered through filter paper (Whatman No. 54) under vacuum followed by drying by rotary evaporation in an Eppendorf concentrator 5301. The resultant pellet was dissolved in 15 ml 20% methanol. The extract was passed through 0.22 µm filter (Sarstedt) and stored at 4 °C until use.
Test Microorganisms
All media was supplied by Oxoid Ltd. All microbial strains were obtained from Tarita Morais, Griffith University. 
Evaluation of Antimicrobial Activity
Antimicrobial activity of each plant extract and was determined using a modified Kirby-Bauer disc diffusion method. [17, 18] Briefly, 100 µl of the test bacteria/fungi were grown in 10 ml of fresh media until they reached a count treatments were performed in at least triplicate. The wells were checked at regular intervals and the number of dead counted. The nauplii were considered dead if no movement of the appendages was observed within 10 seconds. After 72 h all nauplii were sacrificed and counted to determine the total number per well. The LC 50 with 95% confidence limits for each treatment was calculated using probit analysis.
RESULTS AND DISCUSSION
C. citrinus leaf and flower extracts were each diluted to 37 mg/ml. C. salignus leaf and flower extracts were each diluted to 35 mg/ml. 10 µl of each extract was tested in the disc diffusion assay against 17 microorganisms ( Table 1 ). The C. citrinus leaf extract inhibited the growth of 6 of the 14 bacteria tested (43%). The antibacterial activity was strongest against A. faecalis and B. subtilis (as determined by the diameter of the zone of inhibition). C. citrinus flower extract inhibited the growth of 9 of the 14 bacteria tested (64%) with the strongest antibacterial activity against B. cereus and B. subtilis.
The C. salignus leaf extract inhibited the growth of 4 of the 14 bacteria tested (29%) with the stongest inhibitory
Artemia franciscana Nauplii Toxicity Screening
Toxicity was tested using using a modified Artemia franciscana nauplii lethality assay. [21] [22] [23] Artemia franciscana Kellogg cysts were obtained from North American Brine Shrimp, LLC, USA (harvested from the Great Salt Lake, Utah). Synthetic seawater was prepared using Reef Salt, AZOO Co., USA.
2) nauplii were added to wells of a 48 well plate and immediately used for bioassay. The plant extracts were diluted to 5 mg/ml in seawater for toxicity testing, resulting in a 2.5 mg/ml concentration in the bioassay. 400 µl of diluted plant extracts and the reference toxins were transferred to the wells and incubated at 25 ± 1 °C under artificial light (1000 Lux). A negative control (400 µl seawater) was run in at least triplicate for each plate. All of both Gram-positive and Gram-negative bacteria is in agreement with a previous report of the antibacterial activity of a different species of Callistemon (C. rigidus). [15] The greater susceptibility of Gram-positive bacteria is in agreement with previously reported results for South American, [24] African [25, 26] and Australian [27] plant extracts. Results within this laboratory have also confirmed the greater susceptibility of Gram-positive bacteria towards other Australian plant extracts. [17, 18, [28] [29] [30] [31] [32] The Gram-negative bacterial cell wall outer membrane is thought to act as a barrier to many substances including antibiotics. [33] The uptake of the Callistemon extracts antibiotic agents by Gramnegative bacteria is presumably affected by the cell wall outer membrane. In contrast, other studies have demonstrated that Gram-negative bacteria are more susceptible to plant extracts from different Australian plant species. [34] [35] [36] Of the Callistemon extracts tested only C. salignus leaf extract demonstrated any antifungal activity. This extract inhibited the growth of C. albicans but was unable to inhibit A. niger growth. The only yeast tested in these studies (S. cerevisiae), was not inhibited by any of the Callistemon extracts.
The antibacterial activity of the C. citrinus (Figure 1 ) and C. salignus (Figure 2 ) leaf extracts were further investigated effect seen against A. faecalis. C. salignus flower extract inhibited the growth of 6 of the 14 bacteria tested (43%). The antibacterial activity was strongest against A. faecalis, P. flourescens, Y. enterocolitia and B. subtilis (as determined by the diameter of the zone of inhibition). Indeed, C. salignus flower extract was a significantly more effective inhibitor of A. faecalis growth than was the ampicillin control.
Both Gram-positive and Gram-negative bacteria were inhibited by C. citrinus although Gram-positive bacteria were more susceptible. Of the 11 Gram-negative bacteria tested, 3 (27%) were inhibited by C. citrinus leaf extract. The leaf extract inhibited the growth of all of Gram-positive bacteria tested (100%). Likewise, Gram-positive bacteria were more susceptible to C. citrinus flower extract than was Gramnegative bacteria. Of the 11 Gram-negative bacteria tested, 6 were inhibited by C. citrinus flower extract (55%). 100% of the Gram-positive bacteria tested were inhibited by C. citrinus flower extract.
A similar selectivity was seen for C. salignus extracts. C. salignus leaf extract inhibited the growth of 1 of the 11 Gramnegative bacteria tested (9%) compared to 100% of the Gram-positive bacteria. C. salignus flower extract inhibited the growth of 3 of the 11 Gram-negative bacteria tested (27%) and 100% of the Gram-positive bacteria. The ability of C. citrinus and C. salignus extracts to inhibit the growth To further investigate the toxicity of these extracts, LC 50 values were determined by testing across the concentration range 2500 µg/ml to 10 µg/ml in the A. franciscana nauplii bioassay (Table 2 ). For comparison, serial dilutions of potassium dichromate and Mevinphos were also tested. No LC 50 values are reported for the C. citrinus leaf or flower extracts at any time point as no significant increase in mortality above the seawater controls was seen for these extracts at any time tested. This indicates that these extract are non-toxic. Similarly, no LC 50 values are reported for the C. salignus leaf extract at any time point and for the flower extract at 24 and 48h. The C. salignus flower extract does display low toxicity at 72h with an LC 50 value of 1986 ± 210. As LC 50 values ≥ 1000 µg/ml are defined as nontoxic [37] this indicates that the C. salignus flower extracts is also of non-toxicity.
In conclusion, these studies and previous studies within this laboratory [16] show that C. citrinus and C. salignus leaf and flower extracts contain antibacterial components and support the traditional Australian Aborigine medicinal use of Callistemon spp. to protect against infection by both Grampositive and Gram-negative bacteria. As many Callistemon species have been used as a food source [13] and bush medicine [14] by Australian Aborigines for thousands of years, there is To examine the toxicity of the Callistemon extracts, they were tested in the Artemia franciscana nauplii bioassay at a concentration of 2500 µg/ml (Figure 3 ). The C. citrinus leaf (Figure 3a ) and flower ( Figure 3b ) extracts only induced low levels of mortality, similar to the % mortality seen for the seawater control (Figure 3f ) at all time points. Similarly, the C. salignus leaf extract (Figure 3c ) did not induce mortality above that seen for the seawater control at any time point. The C. salignus flower extract (Figure 3d ) induced elevated mortality, although even these results indicate a low level of toxicity, with 72 h exposure needed for >50% mortality induction. In contrast, both postive controls induced can be applied to these purposes. In particular, further toxicity studies are needed to determine the suitability of these extracts for use as antiseptic agents and as a food additive. No studies potential for the use of Callistemon extracts as antisceptic agents and as food additives to protect against spoilage. However, further studies are needed before these extracts Figure 3 : Brine shrimp lethality of (a) C. citrinus leaf methanolic extract (2500 µg/ml), (b) C. citrinus flower methanolic extract (2500 µg/ml), (c) C. salignus leaf methanolic extract (2500 µg/ml), (d) C. salignus flower methanolic extract (2500 µg/ml), (e) potassium dichromate (800 µg/ ml), (f) Mevinphos (2000 µg/ml) and (g) seawater control. All bioassays were performed in at least triplicate and are expressed as mean ± standard error.
of Callistemon toxicity towards human cells was found in the literature. Further studies are needed to fully determine the cytotoxicity of these extracts. These results provide further support the ethnobotanical approach to screening plants as potential sources of bioactive substances. [38] 
